Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cipher Pharmaceuticals Inc
T.CPH
Alternate Symbol(s):
CPHRF
Healthcare
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology...
products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(1)
•••
GJS471
X
View Profile
View Bullboard History
Comment by
GJS471
on May 16, 2022 1:23pm
RE:Q1
I really hope they are not looking at acquisitions. I agree on their dismal record in this regard. But, if they were to improve their portfolio of products, they might become an
...more
(6)
•••
DrewJackson
X
View Profile
View Bullboard History
Comment by
DrewJackson
on May 16, 2022 10:45am
RE:Q1
They also have CF-101 results expected in Q2 2022. $0 debt. $21.9M cash. Monthly NCIB share buybacks. MOB-015 is a long way out, agreed, but could be a huge revenue generator. A bad acquisition
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(164)
•••
Northforce13
X
View Profile
View Bullboard History
Post by
Northforce13
on May 15, 2022 9:28pm
Q1
Nice quarter, nothing to really comment on. 1) MOB 015 = 1.5 years out +/- I suppose 2) Deployment of their 20 mil. They might make some crappy acquisition like they
...more
(1)
•••
GJS471
X
View Profile
View Bullboard History
Post by
GJS471
on May 13, 2022 8:17am
Nice Quarter - but not a reason to sell
The stock price will be lifted today, but for the "longs" out there (like me) my advice is to hold your position. The analysts are going to turn very positive after these results
...more
(126)
•••
Daudau11
X
View Profile
View Bullboard History
Post by
Daudau11
on May 12, 2022 5:36pm
Strong Q1
Cipher Pharmaceuticals Reports Strong First Quarter 2022 Financial Results T.CPH | 35 minutes ago (All figures are in U.S. dollars)
...more
(1)
•••
maxxie3
X
View Profile
View Bullboard History
Comment by
maxxie3
on Mar 31, 2022 6:45pm
RE:CPH Announces Partner Moberg Pharma's FDA Phase 3
MOB-015 MOB-015 is our next-generation nail fungus treatment targeting both over-the-counter (OTC) and prescription markets around the world. The company’s patented formulation technology
...more
(126)
•••
Daudau11
X
View Profile
View Bullboard History
Post by
Daudau11
on Mar 22, 2022 7:02pm
CPH Announces Partner Moberg Pharma's FDA Phase 3
Cipher Pharmaceuticals Announces Partner, Moberg Pharma's Regulatory Submission to FDA for North American Phase 3 Study T.CPH | 2 hours ago
...more
(5)
•••
PitchinPennies
X
View Profile
View Bullboard History
Post by
PitchinPennies
on Mar 18, 2022 10:25am
Impressed
Retaining the equivalent of a buck in cash for each share is a slick trick, no matter how it was achieved. I'm on record here as bleating that Craig Mull doesn't know what he's doing, but
...more
(42)
•••
flashcash
X
View Profile
View Bullboard History
Post by
flashcash
on Mar 18, 2022 7:33am
This is a keeper
Give this one time, I would prefer a divy even a small one though. GLA
(3522)
•••
nozzpack
X
View Profile
View Bullboard History
Comment by
nozzpack
on Mar 18, 2022 7:32am
RE:Q4 Adjusted EBITDA US$4.1 million and US$20.5 million cash
Very good numbers indeed especially product sales continuing to increase . The only negative is the Absorica royalty continues to decline, despite the addition of AG. It would seem that generics are
...more
(1)
•••
Jacks10
X
View Profile
View Bullboard History
Post by
Jacks10
on Mar 17, 2022 6:39pm
BEAUTIFUL !!!
Back to $2.80 we go, probably tomorrow!
(42)
•••
flashcash
X
View Profile
View Bullboard History
Comment by
flashcash
on Mar 11, 2022 1:34am
RE:do i sell or do i hold
It's a long term hold for a pension IMO, 5 years. GLA
(1)
•••
GJS471
X
View Profile
View Bullboard History
Post by
GJS471
on Mar 10, 2022 8:48am
Just announced this morning...
Cipher Pharmaceuticals Announces Extension of Distribution and Supply Agreement with Sun Pharmaceutical Industries Inc. Royalty agreement granting Sun Pharmaceutical Industries Inc. exclusive right
...more
(0)
•••
Rsoleblocka
X
View Profile
View Bullboard History
Post by
Rsoleblocka
on Mar 09, 2022 4:40pm
do i sell or do i hold
if i sell this thing may double, if i hold it may burst my bubble..come on i gotta know, do i sell or do i hold
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >